Advanced in HER2 Negative Breast Cancer

Nicola Battelli

Macerata, IT 
Advanced in HER2 Negative Breast Cancer
Macerata, IT 
OverviewLocationsClinical Research

Overview

Nicola Battelli practices in Macerata, Italy. Ms. Battelli is rated as an Advanced expert by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are Renal Cell Carcinoma (RCC), Triple-Negative Breast Cancer, HER2 Negative Breast Cancer, Breast Cancer, and Nephrectomy.

Her clinical research consists of co-authoring 95 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of HER2 Negative Breast Cancer.

Gender
Female

Locations

Macerata, Italy
Other Locations
Ancona, Italy
Marche, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
Enrollment Status: Terminated
Publish Date: July 15, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
Group Sequential Response Adaptive Randomized Clinical Trial of Concomitant Chemotherapy Plus Endocrine Therapy Versus Cyclin-dependent Kinase 4/6 (CDK4/6) Inhibitor Plus Endocrine Therapy for Advanced Hormone Receptor-positive, HER2-negative Breast Cancer.
Group Sequential Response Adaptive Randomized Clinical Trial of Concomitant Chemotherapy Plus Endocrine Therapy Versus Cyclin-dependent Kinase 4/6 (CDK4/6) Inhibitor Plus Endocrine Therapy for Advanced Hormone Receptor-positive, HER2-negative Breast Cancer.
Enrollment Status: Completed
Publish Date: November 07, 2024
Intervention Type: Drug
Study Drugs: Concomitant Cyclin-Dependent Kinase 4/6 (CDK4/6) Inhibitor plus Endocrine Therapy, Chemotherapy plus Endocrine Therapy
Study Phase: Phase 2
A Randomized Phase II Trial of Metronomic Oral Vinorelbine Plus Cyclophosphamide and Capecitabine (VEX) Versus Weekly Paclitaxel as First-line or Second-line Treatment in Patients With ER-positive/HER2-negative Advanced or Metastatic Breast Cancer
A Randomized Phase II Trial of Metronomic Oral Vinorelbine Plus Cyclophosphamide and Capecitabine (VEX) Versus Weekly Paclitaxel as First-line or Second-line Treatment in Patients With ER-positive/HER2-negative Advanced or Metastatic Breast Cancer
Enrollment Status: Completed
Publish Date: February 26, 2024
Intervention Type: Drug
Study Drugs: Paclitaxel, Cyclophosphamide, Capecitabine, Vinorelbine
Study Phase: Phase 2
View 2 Less Clinical Trials

95 Total Publications

Time to metastasis as a prognostic factor in metastatic urothelial carcinoma: results from the ARON-2 study.
Time to metastasis as a prognostic factor in metastatic urothelial carcinoma: results from the ARON-2 study.
Journal: Clinical & experimental metastasis
Published: May 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Battelli's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile